Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients

NCT06002529 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06002529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06002529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hemodiafiltration With Endogenous Reinfusion on Uremic Toxins Clearance of Maintenance Hemodialysis Patients
Lead sponsor
RenJi Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
August 18, 2023
Completion date
July 1, 2025
Enrollment
20 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

to evaluate the clearance rate of uremic toxin by hfr